Roche Holding AG (RHHVF)
OTCMKTS
· Delayed Price · Currency is USD
306.42
-13.78 (-4.30%)
May 13, 2025, 9:42 AM EDT
Roche Holding AG Revenue
In the year 2024, Roche Holding AG had annual revenue of 62.40B CHF with 3.23% growth. Roche Holding AG had revenue of 31.64B in the half year ending December 31, 2024, a decrease of -0.86%.
Revenue
62.40B CHF
Revenue Growth
+3.23%
P/S Ratio
3.62
Revenue / Employee
604.32K CHF
Employees
103,249
Market Cap
249.33B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Roche Holding AG News
- 23 hours ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha
- 1 day ago - Roche plans $700M North Carolina facility - Seeking Alpha
- 1 day ago - Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub - PRNewsWire
- 1 day ago - Roche to invest $700 million in new drug manufacturing facility in North Carolina - Reuters
- 1 day ago - Roche and Genentech Announce New North Carolina Manufacturing Facility - Business Wire
- 5 days ago - Sarepta Therapeutics Stock Sinks On Gloomy Forecast, Analysts Expect Demand To Pick Up - Benzinga
- 6 days ago - Sarepta Therapeutics Announces First Quarter 2025 Financial Results and Recent Corporate Developments - Benzinga
- 6 days ago - PTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - Benzinga